About the conference

For the 8th time, the Helmholtz Zentrum München is organizing this high-impact conference series. Internationally leading scientists in diabetes research are joining us virtually to present and discuss their most recent data and achievements. Our overriding goal is to find new ways for the prevention and treatment of type 1 and type 2 diabetes. This conference will focus on the genetic and epigenetic mechanisms involved in the development of diabetes. The world’s leading faculty in this area will thus enrich this year’s program. Following our long-standing tradition, we will feature again the HelDi (Helmholtz Young Investigator in Diabetes) competition with selected talks by rising stars in the field of diabetes, and the presentation of the Helmholtz Diabetes Lecture. This year, Susan Bonner-Weir (Harvard University) will receive this award in recognition of her life-time achievements.

The organizers

Stephan Herzig

is Scientific Director of the Helmholtz Diabetes Center (HDC) and the Institute for Diabetes and Cancer (IDC). His lab investigates the molecular mechanisms of diabetes and develops novel, organ-specific compounds to counteract insulin resistance, glucose tolerance and other components of the metabolic syndrome. In addition, he explores the association between cancer development and metabolic dysfunction.

Martin Hrabĕ de Angelis

is Director of the Helmholtz Institute of Experimental Genetics (IEG) and chair of the board of the German Center for Diabetes Research (DZD). His lab investigates the genetics and epigenetics of human diseases with a strong focus on diabetes. Deciphering the molecular underpinning of transgenerational inheritance of acquired metabolic impairment is of special interest.

Robert Schneider

is Director of the Institute of Functional Epigenetic (IFE) at the Helmholtz Zentrum München. His lab is interested in how chromatin can integrate metabolic signals via epigenetic mechanism and in the epigenetic pathways underlying the memory of expression states (e.g of metabolic genes) in single cells through multiple cell divisions.

Helmholtz Zentrum München

Helmholtz Zentrum München, the German Research Center for Environmental Health, develops efficient methods for the early detection, prevention, diagnosis and treatment of important common diseases that arise from the interaction between the environment and individual genetic backgrounds. One major focus of the Center is on diabetes.

More Information

General information

Social Media

Hashtag:
#HelmholtzDiabetes2021

Twitter:

@HelmholtzMunich

@Helmholtz_diabc